To determine whether NIK expression is related to a particular breast cancer subtype, we examine NIK expression by immunohistochemistry, and we found that NIK expression was significantly higher in HER2+ breast carcinomas (Fig. 6B), and the expression of NIK positively correlated with HER2 expression levels (Fig. 6C). Here, ERBB2 is linked to breast cancer.